T. Rowe Price Associates’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-901
| Closed | -$19K | – | 2973 |
|
|
2023
Q4 | $19K | Buy |
901
+112
| +14% | +$3.34K | ﹤0.01% | 2876 |
|
|
2023
Q3 | $26K | Sell |
789
-727
| -48% | -$24.3K | ﹤0.01% | 2839 |
|
|
2023
Q2 | $51K | Buy |
1,516
+789
| +109% | +$28.2K | ﹤0.01% | 2801 |
|
|
2023
Q1 | $31K | Hold |
727
| – | – | ﹤0.01% | 2829 |
|
|
2022
Q4 | $25K | Hold |
727
| – | – | ﹤0.01% | 2868 |
|
|
2022
Q3 | $36K | Hold |
727
| – | – | ﹤0.01% | 2870 |
|
|
2022
Q2 | $29K | Buy |
727
+149
| +26% | +$4.42K | ﹤0.01% | 2911 |
|
|
2022
Q1 | $21K | Buy |
578
+113
| +24% | +$7.07K | ﹤0.01% | 2956 |
|
|
2021
Q4 | $45K | Sell |
465
-47
| -9% | -$5.06K | ﹤0.01% | 2929 |
|
|
2021
Q3 | $64K | Buy |
512
+25
| +5% | +$3.02K | ﹤0.01% | 2893 |
|
|
2021
Q2 | $61K | Buy |
+487
| New | +$58K | ﹤0.01% | 2888 |
|
|
2020
Q1 | – | Sell |
-2,713
| Closed | -$194K | – | 2552 |
|
|
2019
Q4 | $194K | Sell |
2,713
-762
| -22% | -$36.8K | ﹤0.01% | 2411 |
|
|
2019
Q3 | $182K | Sell |
3,475
-2,721
| -44% | -$145K | ﹤0.01% | 2398 |
|
|
2019
Q2 | $333K | Sell |
6,196
-27
| -0.4% | -$1.84K | ﹤0.01% | 2272 |
|
|
2019
Q1 | $442K | Sell |
6,223
-1,773
| -22% | -$112K | ﹤0.01% | 2164 |
|
|
2018
Q4 | $638K | Buy |
7,996
+30
| +0.4% | +$6.85K | ﹤0.01% | 1986 |
|
|
2018
Q3 | $3.72M | Buy |
7,966
+11
| +0.1% | +$4.42K | ﹤0.01% | 1490 |
|
|
2018
Q2 | $3.16M | Buy |
7,955
+7
| +0.1% | +$2.48K | ﹤0.01% | 1498 |
|
|
2018
Q1 | $2.43M | Buy |
7,948
+1
| +0% | +$285 | ﹤0.01% | 1530 |
|
|
2017
Q4 | $2.34M | Buy |
7,947
+3
| +0% | +$1.31K | ﹤0.01% | 1546 |
|
|
2017
Q3 | $4.35M | Hold |
7,944
| – | – | ﹤0.01% | 1458 |
|
|
2017
Q2 | $4.73M | Buy |
7,944
+2,864
| +56% | +$1.27M | ﹤0.01% | 1420 |
|
|
2017
Q1 | $2.18M | Sell |
5,080
-3,200
| -39% | -$1.35M | ﹤0.01% | 1558 |
|
|
2016
Q4 | $4.26M | Buy |
+8,280
| New | +$4.84M | ﹤0.01% | 1438 |
|
Other funds holding RNAC
AG
EAM
